Lifeworks Advisors’s Celanese CE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-31,305
Closed -$1.78M 315
2025
Q1
$1.78M Buy
31,305
+12,166
+64% +$760K 0.3% 85
2024
Q4
$1.32M Buy
19,139
+5,836
+44% +$561K 0.24% 104
2024
Q3
$1.81M Buy
13,303
+2,786
+26% +$366K 0.36% 82
2024
Q2
$1.42M Sell
10,517
-1,369
-12% -$209K 0.4% 70
2024
Q1
$2.04M Buy
11,886
+567
+5% +$86.3K 0.57% 54
2023
Q4
$1.76M Buy
11,319
+7,336
+184% +$957K 0.61% 53
2023
Q3
$500K Sell
3,983
-8,838
-69% -$1.09M 0.19% 122
2023
Q2
$1.48M Buy
12,821
+2,446
+24% +$265K 0.63% 49
2023
Q1
$1.13M Sell
10,375
-739
-7% -$85.3K 0.53% 67
2022
Q4
$1.14M Sell
11,114
-71
-0.6% -$7.04K 0.64% 53
2022
Q3
$1.07M Buy
11,185
+2,172
+24% +$239K 0.61% 57
2022
Q2
$1.06M Buy
9,013
+3,186
+55% +$457K 0.67% 45
2022
Q1
$833K Buy
5,827
+3,053
+110% +$466K 0.55% 63
2021
Q4
$466K Buy
+2,774
New +$452K 0.37% 80

Other funds holding CE

Lifeworks Advisors's CE Position: Q2 2025 in Review

Lifeworks Advisors sold out of Celanese (CE) in Q2 2025, closing a stake of 31,305 shares — an estimated $1.78M sold.

Lifeworks Advisors first reported a position in CE in Q4 2021 and held it in 14 quarters. The position peaked at $2.04M in Q1 2024. 448 funds tracked by Wall St. Rank hold CE as of Q2 2025.

  • Lifeworks Advisors reported no remaining Celanese position as of Q2 2025 after selling out during the quarter.
  • Lifeworks Advisors sold 31,305 Celanese shares in Q2 2025, an estimated $1.78M.
  • Lifeworks Advisors first reported a position in Celanese in Q4 2021 and held it in 14 quarters.
  • Lifeworks Advisors's Celanese position peaked at $2.04M in Q1 2024.
  • 448 funds tracked by Wall St. Rank held Celanese as of Q2 2025.

Based on Lifeworks Advisors's 13F filing for Q2 2025, filed 5 Aug 2025.